Compare Illumina, Inc. (ILMN) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs SoundHound AI Inc — how do they compare? Illumina, Inc. trades at $191.18 (market cap $29.12B), while SoundHound AI Inc trades at $7.39 (market cap $3.29B). The key difference: Illumina, Inc. is far larger — about 8.9× SoundHound AI Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | SOUN | |
|---|---|---|
Market Cap | $29.12B | $3.29B |
Sector | Health | Technology |
52-Week High | $205.10 | $21.40 |
52-Week Low | $91.00 | $5.70 |
Enterprise Value | $30.48B | $3.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $191.32, down 0.25% on the day, with a bullish earnings trend after beating Q2 2026 estimates. The stock shows strong profitability with a net margin of 18.34% and positive cash flow, though technical indicators signal near-term bearish pressure. Recent news highlights institutional buying and AI partnerships boosting growth prospects.
Outlook remains positive with a consensus price target of $201.58, offering ~5% upside, supported by solid fundamentals and analyst optimism. Risks include high valuation multiples and competitive pressures in genomics. The stock presents a growth opportunity with manageable near-term volatility.
SoundHound AI (SOUN) trades at $7.395, down 0.87% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations, revenue grew 45% year-over-year to $61.9 million, and the company raised its 2026 revenue guidance, driven by its OASYS platform. However, the stock faces headwinds from negative net income margins and high cash burn.
The outlook is cautiously optimistic with 75% of analysts rating it Buy and a $8.50 consensus target, but profitability challenges and premium valuations pose risks. Key catalysts include the pending LivePerson acquisition and OASYS adoption, while execution on path to profitability remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
